Literature DB >> 17963755

Altered expression of cyclooxygenase-2, presenilins and oxygen radical scavenging enzymes in a rat model of global perinatal asphyxia.

Paola Piscopo1, Antonietta Bernardo, Gemma Calamandrei, Aldina Venerosi, Angela Valanzano, Daniela Bianchi, Annamaria Confaloni, Luisa Minghetti.   

Abstract

Cyclooxygenase-2 (COX-2) and presenilin (PSEN) 1 and 2 genes are regulated during development as well as in pathological conditions associated to hypoxia. In this study, we investigated their patterns of expression during the first 2 weeks of postnatal life in a rat model of moderate global perinatal asphyxia that we have previously reported to be characterized by early oxidative stress and delayed behavioral alterations. In the hippocampus, global perinatal asphyxia induced an early up-regulation COX-2 mRNA (postnatal day, pnd, 1), which preceded those of PSEN 1 and 2 genes, observed at pnd 4. At pnd 11, the expression of all three genes was decreased compared to control animals. In addition, we analyzed the expression of the scavenging enzymes catalase, copper/zinc- and manganese-superoxide dismutase. As for COX-2, the three enzymes were up-regulated in the hippocampus at pnd 1 and returned at or below baseline by pnd 4. In the cortex, only PSEN 1 and 2 showed a moderate up-regulation at pnd 1 followed by a down-regulation at pnd 11. These findings suggest that moderate perinatal hypoxic episodes are associated with a dysregulation of the several genes involved in brain development and anti-oxidant defenses, which follows a rapid and transient oxidative stress. Such alterations are particularly evident in the hippocampus and could represent an adaptive response to the hypoxic condition. The delayed down-regulation of the scavenging enzymes could set the ground for brain damage and delayed behavioral alterations and further support the potential benefit of early anti-oxidant treatments in a short therapeutic window soon after birth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963755     DOI: 10.1016/j.expneurol.2007.09.014

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  6 in total

1.  Gene expression profiles of APP and BACE1 in Tg SOD1G93A cortical cells.

Authors:  Ornella Spadoni; Alessio Crestini; Paola Piscopo; Lorenzo Malvezzi-Campeggi; Irene Carunchio; Massimo Pieri; Cristina Zona; Annamaria Confaloni
Journal:  Cell Mol Neurobiol       Date:  2009-02-13       Impact factor: 5.046

2.  Presenilin-1 regulates induction of hypoxia inducible factor-1α: altered activation by a mutation associated with familial Alzheimer's disease.

Authors:  Rita De Gasperi; Miguel A Gama Sosa; Stella Dracheva; Gregory A Elder
Journal:  Mol Neurodegener       Date:  2010-09-23       Impact factor: 14.195

Review 3.  Role of early life exposure and environment on neurodegeneration: implications on brain disorders.

Authors:  Shweta Modgil; Debomoy K Lahiri; Vijay L Sharma; Akshay Anand
Journal:  Transl Neurodegener       Date:  2014-04-29       Impact factor: 8.014

Review 4.  Targeting Sentinel Proteins and Extrasynaptic Glutamate Receptors: a Therapeutic Strategy for Preventing the Effects Elicited by Perinatal Asphyxia?

Authors:  Mario Herrera-Marschitz; Ronald Perez-Lobos; Carolyne Lespay-Rebolledo; Andrea Tapia-Bustos; Emmanuel Casanova-Ortiz; Paola Morales; Jose-Luis Valdes; Diego Bustamante; Bruce K Cassels
Journal:  Neurotox Res       Date:  2017-08-26       Impact factor: 3.911

5.  Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists.

Authors:  Antonietta Bernardo; Luisa Minghetti
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

6.  Reduced miR-659-3p Levels Correlate with Progranulin Increase in Hypoxic Conditions: Implications for Frontotemporal Dementia.

Authors:  Paola Piscopo; Margherita Grasso; Francesca Fontana; Alessio Crestini; Maria Puopolo; Valerio Del Vescovo; Aldina Venerosi; Gemma Calamandrei; Sebastian F Vencken; Catherine M Greene; Annamaria Confaloni; Michela A Denti
Journal:  Front Mol Neurosci       Date:  2016-05-03       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.